Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
You could win a cash prize of up to £25,000 when you play the JDRF lottery. As well as the chance to win great prizes, you'll also help fund our research to find a cure for type 1 diabetes.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join us on Saturday 21 September 2024 with hundreds of JDRF supporters celebrating One Walk Belfast!
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF is undergoing a transformation.We are becoming Breakthrough T1D in October.
Home > News & events > News > Phil Aird-Mash appointed as new Chair of JDRF
Phil Aird-Mash, CEO of the ITC Travel Group, Chair of ACC Aviation and Traveltek Ltd has been appointed JDRF’s Chair of the Board of Directors after a competitive recruitment process.
Phil has served on the JDRF Board since 2019 and has been Vice Chair since 2021. He was diagnosed with type 1 diabetes at the age of 28.
He says: “JDRF is a charity close to my heart. I consider myself fortunate that I was diagnosed swiftly and with great support from healthcare professionals and my family and friends. Since this time, I have always given much thought to the impact type 1 has on families, in particular on children who are diagnosed with the condition.
JDRF’s research to find a cure, alongside its work to support and improve the health, wellbeing and quality of life of those affected, has tremendous personal resonance. I am delighted to be able to use my skills, experience and networks to help the cause.”
JDRF’s current chairman David McTurk, will be stepping down from his role at the end of his term of office at the end of December 2022. David has been involved in JDRF for 21 years and as Chair since 2019 he has helped to steer JDRF through the uncertain times of the Covid pandemic.
David says: “JDRF has been a very important part of my life. However, I have decided that now is the right time for me to step down as I move fully into retirement, and it is an opportunity for fresh thinking and increased impetus on the Board as we face the new challenges ahead of us.
I am delighted that we have been able to appoint Phil Aird-Mash as our new Chair. He is absolutely the right person for the job, and I know very well he will lead JDRF with great vision and determination.”
JDRF’s Chief Executive Karen adds: “I feel extremely fortunate to have had the opportunity to work with David over the past three years. His energy, experience and enthusiasm for what we do here at JDRF has been invaluable, especially over the course of the pandemic.
While we’ll be incredibly sad to say goodbye to David, I look forward to welcoming Phil into the new role of Chair. Phil takes on this role at an exciting time for JDRF as we look to build on the firm foundation that David has helped us to build. His business acumen and lived experience of Type 1 diabetes will help us to continue our mission to eradicate type 1 and its effects.”
The leading global type 1 diabetes charity, JDRF International (JDRF) is proud to unveil its new brand and name, Breakthrough T1D. The new name embodies its mission to cure and treat type 1 diabetes (T1D), while supporting everyone who lives with the condition.
It's been an incredible year for advancements in type 1 diabetes research and treatments. We take a look at the progress we made in 2023, funded by you, our supporters.
We’re pleased to announce the appointment of two new Board Directors, Nadia Swann and Sarah Johnson.
A lot has happened over the last 12 months at JDRF, and in the world of type 1 diabetes as a whole. From research breakthroughs to herculean fundraising efforts, here’s a retrospective of everything we’ve been celebrating in 2022.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
Please note that your consent will be valid across all our subdomains. You can change or withdraw your consent at any time by clicking the “Consent Preferences” button at the bottom of your screen. We respect your choices and are committed to providing you with a transparent and secure browsing experience.
